A review highlights CGRP as a potential therapeutic target in heart failure, acting through vasodilation, cardioprotection, anti-inflammatory, and anti-fibrotic mechanisms.
Multi-mechanism cardioprotectionCGRP provides vasodilation, anti-inflammation, and anti-fibrosis relevant to heart failure
What the researchers found
CGRP offers multiple cardioprotective mechanisms — vasodilation, anti-inflammation, anti-fibrosis, and neurohormonal counterregulation — that may be therapeutically exploitable in heart failure.
Why it matters
Current heart failure treatments have limitations. CGRP-based therapies could provide a novel approach addressing multiple pathological mechanisms simultaneously.
How the study worked
Narrative review of CGRP biology and its role in cardiovascular homeostasis and heart failure pathophysiology.
What this study cannot tell us
Narrative review — mostly based on preclinical evidence; clinical translation of CGRP modulation for heart failure is still theoretical.
How to read the evidence
Narrative review — synthesizes preclinical and mechanistic evidence; clinical data on CGRP modulation for HF is limited.
When this study was published
Published 2026 in Cardiovascular Drugs and Therapy.
The bigger picture
CGRP is already targeted in migraine treatment (anti-CGRP antibodies). Understanding its cardiovascular role is important to ensure migraine treatments don't inadvertently harm the heart, and to develop cardiac-specific CGRP therapies.
Questions still open
- Do anti-CGRP migraine drugs adversely affect cardiac function?
- Can CGRP agonists be developed specifically for heart failure treatment?
Common questions
What is CGRP's role in the heart?
Could migraine drugs that block CGRP harm the heart?
Read the original research
Modulating CGRP Signaling: A Promising Therapeutic Avenue for Attenuating Cardiac Dysfunction in Heart Failure.
Cardiovascular drugs and therapy
Citation
Ansari, Shazia; Aran, Khadga Raj. (2026). Modulating CGRP Signaling: A Promising Therapeutic Avenue for Attenuating Cardiac Dysfunction in Heart Failure.. Cardiovascular drugs and therapy. https://doi.org/10.1007/s10557-025-07830-x